Jeremy Schurman
About Jeremy Schurman
Jeremy Schurman is a Senior Manager of Commercial Programs at Singular Genomics, with a robust background in biotechnology and sales operations. He holds an MBA and a BS in Molecular Biology from the University of California, San Diego, and has extensive experience in start-ups and team management.
Work at Singular Genomics
Jeremy Schurman currently serves as the Senior Manager of Commercial Programs at Singular Genomics. He has held this position since 2021, contributing to the company's initiatives in the biotechnology sector. His role involves overseeing commercial strategies and programs that support the advancement of genomics for scientific and medical purposes.
Previous Experience at ecoATM Gazelle
Prior to his current role, Jeremy Schurman worked at ecoATM Gazelle in various capacities. He served as the Director of Sales Operations for seven months in 2020 to 2021, and before that, he was the Senior Channel Sales Manager from 2016 to 2020. Additionally, he held the position of Manager of Business Development from 2013 to 2016. His tenure at ecoATM Gazelle spanned nearly eight years, during which he developed expertise in sales operations and business development.
Education and Expertise
Jeremy Schurman earned a Master of Business Administration (MBA) from the University of California, San Diego - The Rady School of Management, where he studied from 2010 to 2012. He also holds a Bachelor of Sciences in Molecular Biology from UC San Diego, obtained between 2003 and 2007. His educational background supports his strong expertise in project management, sales, and team building, particularly within the biotechnology sector.
Background in Biotechnology
Jeremy Schurman has a robust background in biotechnology, focusing on accelerating genomics for scientific and medical advancements. His career history predominantly involves working in start-ups, showcasing his adaptability and innovative mindset. This experience positions him well to contribute to the evolving landscape of biotechnology and genomics.